Abstract
Rationale Severe early-life respiratory illnesses, particularly those caused by respiratory syncytial virus (RSV) and human rhinovirus (HRV), are strongly associated with the development of asthma in children. Puerto Rican children in particular have a strikingly high asthma burden, but prior studies of the potential associations between early-life respiratory illnesses and asthma in Puerto Rican and other minority populations have been limited.
Objectives We sought to determine whether early-life respiratory illness was associated with asthma in Puerto Rican children relative to other minority children.
Methods Using a logistic regression analysis, we examined the association between early-life respiratory illnesses (report of upper respiratory infection (URI), pneumonia, bronchitis, and bronchiolitis/RSV) within the first two years of life and physician-diagnosed asthma after the age of two in a large cohort of minority children.
Measurements and Main Results Early-life respiratory illnesses were associated with greater asthma risk in Puerto Ricans relative to other racial/ethnic minority populations. Specifically, in Puerto Ricans, the odds was 6.15 (95% CI: 4.21-9.05) if the child reported at least one of the following respiratory illness: URI, pneumonia, bronchitis or bronchiolitis. The odds were also higher in Puerto Ricans when considering these conditions separately.
Conclusions We observe population-specific associations between early-life respiratory illnesses and asthma, which was especially significant in Puerto Ricans. Taken together with the known high burden of RSV in Puerto Rico, our results may help explain the high burden of asthma in Puerto Ricans.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by the Sandler Family Foundation, the American Asthma Foundation, the RWJF Amos Medical Faculty Development Program, Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II, National Institutes of Health R01HL117004, R01HL128439, R01HL135156, 1X01HL134589, R01HL141992, 5T32GM007546, National Institute of Health and Environmental Health Sciences R01ES015794, R21ES24844, the National Institute on Minority Health and Health Disparities P60MD006902 RL5GM118984, R01MD010443 and the Tobacco-Related Disease Research Program under Award Number 24RT-0025, 27IR-0030
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest statement The authors declare that they have no relevant conflicts of interest.
Funding Sources This work was supported in part by the Sandler Family Foundation, the American Asthma Foundation, the RWJF Amos Medical Faculty Development Program, Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II, National Institutes of Health R01HL117004, R01HL128439, R01HL135156, 1X01HL134589, R01HL141992, 5T32GM007546, National Institute of Health and Environmental Health Sciences R01ES015794, R21ES24844, the National Institute on Minority Health and Health Disparities P60MD006902 RL5GM118984, R01MD010443 and the Tobacco-Related Disease Research Program under Award Number 24RT-0025, 27IR-0030
Abbreviations RSV, respiratory syncytial virus; HRV, human rhinovirus; GALA II, Genes-Environments and Admixture in Latino Americans; SAGE, The Study of African Americans, Asthma, Genes and Environments; URI, upper respiratory infection; SES, socioeconomic status
Data Availability
Due to the sensitive nature of the data collected surrounding issues of race, socioeconomic status, and ancestry, data are available upon request. Access to the limited dataset used in this study can be arranged by contacting Dr. Esteban Burchard [email: esteban.burchard{at}ucsf.edu]. Of note, any data provided will be stripped of specific subject identifiers that could be used to identify a specific child and/or his/her residence. All source code for this analysis can be accessed on our github page https://github.com/asthmacollaboratory/asthma-after-RI.
